Stock WELL WELL HEALTH TECHNOLOGIES CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Financials WELL Health Technologies Corp.

Equities

WELL

CA94947L1022

Healthcare Facilities & Services

Delayed Toronto S.E.
Other stock markets
 03:24:26 2024-05-10 pm EDT 		5-day change 1st Jan Change
3.91 CAD -2.98% Intraday chart for WELL Health Technologies Corp. +9.83% +1.56%
May. 08 WELL Health Technologies Posts Q1 Adjusted Earnings and Revenues Beat; Also Flags 2024 Revenues Beat and Free Cash Flow Improvement MT
May. 08 Well Health Brief: increasing its guidance range for 2024 annual revenue of between $960-$980 million, while guiding to upper range of its previous Adjusted EBITDA guidance of $125-$130 million MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 179.6 1,307 1,022 653.6 929.5 990.4 - -
Enterprise Value (EV) 1 168.7 1,307 1,297 898 1,231 1,248 1,197 990.4
P/E ratio -19.5 x -268 x -21.3 x - - -31 x -806 x 40.3 x
Yield - - - - - - - -
Capitalization / Revenue 5.48 x 26 x 3.38 x 1.15 x 1.2 x 1.03 x 0.95 x 0.9 x
EV / Revenue 5.14 x 26 x 4.29 x 1.58 x 1.59 x 1.3 x 1.15 x 0.9 x
EV / EBITDA -98.5 x -14,209 x 21.5 x 8.59 x 10.9 x 9.81 x 8.04 x 6.28 x
EV / FCF - -201 x 66.2 x 12.8 x 21.1 x 19.6 x 12.6 x -
FCF Yield - -0.5% 1.51% 7.81% 4.74% 5.11% 7.91% -
Price to Book 0.05 x - - - - - - -
Nbr of stocks (in thousands) 115,159 162,404 208,166 230,153 241,428 245,760 - -
Reference price 2 1.560 8.050 4.910 2.840 3.850 4.030 4.030 4.030
Announcement Date 3/31/20 3/18/21 3/31/22 3/21/23 3/21/24 - - -
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 32.81 50.24 302.3 569.1 776.1 962.9 1,044 1,094
EBITDA 1 -1.713 -0.092 60.36 104.6 113.4 127.1 149 157.7
EBIT 1 -6.086 -10.41 -12.79 23.31 - 50.75 82.35 122.2
Operating Margin -18.55% -20.71% -4.23% 4.1% - 5.27% 7.89% 11.17%
Earnings before Tax (EBT) 1 -7.759 -6.986 -24.97 17.92 - -3.264 40.03 81.7
Net income 1 -7.819 -3.686 -43.79 1.369 - -30 2.8 25
Net margin -23.83% -7.34% -14.48% 0.24% - -3.12% 0.27% 2.28%
EPS 2 -0.0800 -0.0300 -0.2300 - - -0.1300 -0.005000 0.1000
Free Cash Flow 1 - -6.517 19.59 70.14 58.33 63.7 94.7 -
FCF margin - -12.97% 6.48% 12.32% 7.52% 6.62% 9.07% -
FCF Conversion (EBITDA) - - 32.45% 67.08% 51.44% 50.11% 63.57% -
FCF Conversion (Net income) - - - 5,123.59% - - 3,382.11% -
Dividend per Share - - - - - - - -
Announcement Date 3/31/20 3/18/21 3/31/22 3/21/23 3/21/24 - - -
1CAD in Million2CAD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 115.7 126.5 140.3 145.8 156.5 169.4 170.9 204.5 231.2 231.6 236 242.9 254.4 253 258.6
EBITDA 1 25.68 23.49 26.43 27.46 27.17 26.68 27.79 28.17 30.75 28.31 29.85 33.16 36.14 33.36 36.19
EBIT 1 6.848 7.374 6.324 8.578 2.288 8.759 10.11 7.079 - 8.853 11.2 14 17.7 18.2 19.3
Operating Margin 5.92% 5.83% 4.51% 5.88% 1.46% 5.17% 5.91% 3.46% - 3.82% 4.75% 5.76% 6.96% 7.19% 7.46%
Earnings before Tax (EBT) 1 2.287 -0.039 -3.025 3.785 18.36 -10.44 -0.127 -4.507 - 19.42 -1.858 1.933 4.936 7.6 12.7
Net income 1 -8.803 -8.019 -5.903 -4.419 20.63 -14.36 -5.767 -7.606 - 15.09 -7.9 - -4 0.7 4.1
Net margin -7.61% -6.34% -4.21% -3.03% 13.18% -8.47% -3.37% -3.72% - 6.52% -3.35% - -1.57% 0.28% 1.59%
EPS 2 -0.0400 -0.0400 -0.0300 -0.0200 0.0900 -0.0600 -0.0300 -0.0300 - 0.0600 -0.0225 -0.0267 -0.0125 -0.005000 0.005000
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 3/31/22 5/11/22 8/11/22 11/10/22 3/21/23 5/12/23 8/10/23 11/14/23 3/21/24 5/8/24 - - - - -
1CAD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - 275 244 302 257 207 -
Net Cash position 1 10.9 - - - - - - -
Leverage (Debt/EBITDA) - - 4.549 x 2.337 x 2.66 x 2.024 x 1.389 x -
Free Cash Flow 1 - -6.52 19.6 70.1 58.3 63.7 94.7 -
ROE (net income / shareholders' equity) - - - - - - - -
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share 33.00 - - - - - - -
Cash Flow per Share -0.0300 -0.0400 - - - - - -
Capex 1 0.47 1.13 2.68 6.4 8.11 9.1 9.18 9.2
Capex / Sales 1.44% 2.26% 0.89% 1.13% 1.04% 0.94% 0.88% 0.84%
Announcement Date 3/31/20 3/18/21 3/31/22 3/21/23 3/21/24 - - -
1CAD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for WELL Health Technologies Corp.

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
4.03 CAD
Average target price
7.391 CAD
Spread / Average Target
+83.39%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
WELL HEALTH TECHNOLOGIES CORP. Stock WELL Health Technologies Corp.
+4.68% 724M
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+18.92% 84.31B
CVS HEALTH CORPORATION Stock CVS Health Corporation
-29.48% 69.9B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+9.65% 29.06B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
-0.14% 17.01B
LABORATORY CORPORATION OF AMERICA HOLDINGS Stock Laboratory Corporation of America Holdings
-9.30% 17.38B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
+0.20% 15.35B
REDE D'OR SÃO LUIZ S.A. Stock Rede D'Or São Luiz S.A.
+5.25% 12.91B
TENET HEALTHCARE CORPORATION Stock Tenet Healthcare Corporation
+68.96% 12.47B
EUROFINS SCIENTIFIC SE Stock Eurofins Scientific SE
-2.88% 11.9B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. WELL Stock
  4. Financials WELL Health Technologies Corp.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW